Comprehensive care of the patient with idiopathic pulmonary fibrosis

被引:61
作者
Lee, Joyce S. [1 ]
McLaughlin, Sally [2 ]
Collard, Harold R. [1 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Med Ctr, San Francisco, CA USA
关键词
disease management; idiopathic pulmonary fibrosis; management; palliative care; treatment; PLACEBO-CONTROLLED TRIAL; LUNG TRANSPLANTATION; PROGNOSTIC-SIGNIFICANCE; N-ACETYLCYSTEINE; CHRONIC COUGH; SURVIVAL; PIRFENIDONE; THERAPY; DYSPNEA; REHABILITATION;
D O I
10.1097/MCP.0b013e328349721b
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose of review Recently, an expert committee endorsed by the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and the Latin American Thoracic Society published an evidence-based guideline on the management of idiopathic pulmonary fibrosis (IPF). In the current document, we summarize and supplement this recent expert document and propose a comprehensive approach to the care and management of patients with IPF. Recent findings We propose three pillars of care for the patient with IPF titled 'disease-centered management', 'symptom-centered management', and 'education and self-management'. Disease-centered management involves both pharmacological and nonpharmacological approaches. Palliative care should be an integral and routine component of the care of patients with IPF. Education and self-management strengthens the provider-patient partnership by enabling patients to set realistic goals, remain in control of his or her care, and prepare for the future. Summary The comprehensive care of the patient with IPF involves balancing the three pillars of disease-centered management, symptom-centered management, and patient education and self-management upon a solid foundation of provider-patient partnership. Constant reassessment of the individual patient's goals of care, based on their values and preferences, is essential to the constant recalibration of these various interventions.
引用
收藏
页码:348 / 354
页数:7
相关论文
共 44 条
[1]   Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis [J].
Allen, S ;
Raut, S ;
Woollard, J ;
Vassallo, M .
PALLIATIVE MEDICINE, 2005, 19 (02) :128-130
[2]   Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis [J].
Antoniou, K. M. ;
Nicholson, A. G. ;
Dimadi, M. ;
Malagari, K. ;
Latsi, P. ;
Rapti, A. ;
Tzanakis, N. ;
Trigidou, R. ;
Polychronopoulos, V. ;
Bouros, D. .
EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (03) :496-504
[3]   Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis - Adjunctive therapy to maintenance immunosuppression [J].
Behr, J ;
Maier, K ;
Degenkolb, B ;
Krombach, F ;
Vogelmeier, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (06) :1897-1901
[4]   Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis [J].
Bjoraker, JA ;
Ryu, JH ;
Edwin, MK ;
Myers, JL ;
Tazelaar, HD ;
Schroeder, DR ;
Offord, KP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (01) :199-203
[5]   Chronic cough due to chronic interstitial pulmonary diseases - ACCP evidence-based clinical practice guidelines [J].
Brown, KK .
CHEST, 2006, 129 (01) :180S-185S
[6]   Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis [J].
Collard, HR ;
Ryu, JH ;
Douglas, WW ;
Schwarz, MI ;
Curran-Everett, D ;
King, TE ;
Brown, KK .
CHEST, 2004, 125 (06) :2169-2174
[7]   Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis [J].
Collard, HR ;
King, TE ;
Bartelson, BB ;
Vourlekis, JS ;
Schwarz, MI ;
Brown, KK .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :538-542
[8]  
Davies H.R., 2003, Cochrane Database Syst Rev, DOI [DOI 10.1002/14651858.CD003134, 10.1002/14651858.CD003134]
[9]   High-dose acetylcysteine in idiopathic pulmonary fibrosis [J].
Demedts, M ;
Behr, J ;
Buhl, R ;
Costabel, U ;
Dekhuijzen, R ;
Jansen, HM ;
MacNee, W ;
Thomeer, M ;
Wallaert, B ;
Laurent, F ;
Nicholson, AG ;
Verbeken, EK ;
Verschakelen, J ;
Flower, CDR ;
Capron, F ;
Petruzzelli, S ;
De Vuyst, P ;
van den Bosch, JMM ;
Rodriguez-Becerra, E ;
Corvasce, G ;
Lankhorst, I ;
Sardina, M ;
Montanari, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21) :2229-2242
[10]   Idiopathic pulmonary fibrosis - Impact of oxygen and colchicine, prednisone, or no therapy on survival [J].
Douglas, WW ;
Ryu, JH ;
Schroeder, DR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (04) :1172-1178